Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G3OI
|
|||
| Former ID |
DNCL002032
|
|||
| Drug Name |
MK-8237
|
|||
| Indication | Allergic asthma [ICD-11: CA23.0; ICD-10: J45.0] | Phase 3 | [1] | |
| Company |
ALK-Abello; Merck
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01700192) Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.